Atlas Trials

The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation

Clinical trial NCT04626427 · TERMINATED

Trial details

NCT number
NCT04626427
Sponsor
C. R. Bard
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
End Stage Kidney DiseaseChronic Kidney DiseasesKidney FailureKidney InsufficiencyKidney Disease, ChronicAV FistulaFistulas Arteriovenous
Start date
2020-12-23
Primary completion
2022-06-15
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.